通过MARS®平台分选 CD3- CD56+ NK 细胞
![](https://appliedcells.com/wp-content/uploads/apc-resources-app-note-thumb-AC_ACh027A-NK-CD3-CELLS_Page_1-1024x1024.png)
NK细胞是目前肿瘤免疫治疗领域主要的创新目标。开发和改造基于NK细胞的癌症免疫疗法需要清洁且高效的小体积和大规模的细胞分离方法。创新产品MARS®Bar系统为CD56+/CD3-细胞分离提供了新一代大规模、磁分离技术,可以从单采血、全血或骨髓细胞制品中进行分离。
CD3- CD56+ NK Cell Selection with MARS® Platform
![Application note highlighting CD3- CD56+ NK Cell Selection with MARS Bar Platform](https://appliedcells.com/wp-content/uploads/apc-resources-app-note-thumb-A027.png)
NK cells are currently a major target of innovation in the field of cancer immunotherapy. Efforts aimed at developing and engineering NK cell-based cancer immunotherapy require clean and efficient methods of cell isolation at both small and large scales. The new MARS® Bar system enables a new generation of large scale, magnetic CD56+/CD3- cell isolation […]
NK cell isolation with MARS® Platform
![](https://appliedcells.com/wp-content/uploads/apc-A0015A-NK.jpg)
Over the last years, NK cells have gained significant attention in the field of cancer immunotherapy and many efforts are emerging for developing and engineering NK cell-based cancer immunotherapy. Obtaining a large quantity of NK cells requires a democratized cell isolation solution for both pre-clinical and clinical applications. The new MARS Bar system enables a […]